Pinak B. Shah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Pinak B. Shah has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Alistair Phillips
American College of Cardiology Cardiac Surgery Team and Leadership Council, Washington, DC; The Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio
1 shared publicationDavid Fullerton
American College of Cardiology Cardiac Surgery Team and Leadership Council, Washington, DC; Division of Cardiothoracic Surgery, University of Colorado School of Medicine, Denver, Colorado
1 shared publicationDee Dee Wang
Henry Ford Health System, Center for Structural Heart Disease, Wayne State University School of Medicine, Detroit, Michigan
1 shared publicationEhtisham Mahmud
Society for Cardiovascular Angiography and Interventions, Washington, DC; Division of Cardiovascular Medicine, University of California-San Diego, San Diego, California
1 shared publicationFrederick G.P. Welt
American College of Cardiology Interventional Cardiology Section Leadership Council, Washington, DC; Cardiovascular Division, University of Utah Health, Salt Lake City, Utah
1 shared publicationJames Hermiller
Society for Cardiovascular Angiography and Interventions, Washington, DC; Ascension Medical Group, Indianapolis, Indiana
1 shared publication
Latest Publications
- 6 April 2020
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 13 (12) , 1484-1488
Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic
- 6 April 2020
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 13 (12) , 1484-1488
Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic
- 1 July 2017
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 10 (14) , 1464-1465
Percutaneous Closure of a Delayed Left Ventricular Pseudoaneurysm After Transseptal Transcatheter Mitral Valve Replacement
- 1 July 2017
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 10 (14) , 1464-1465
Percutaneous Closure of a Delayed Left Ventricular Pseudoaneurysm After Transseptal Transcatheter Mitral Valve Replacement
- 26 April 2011
- Published by Wolters Kluwer Health in Circulation
- Vol. 123 (16) , 1780-1784
Management of Coronary Chronic Total Occlusion
A 67-year-old man with chronic stable angina presented with worsening angina to class III despite maximal medical therapy. He was referred for myocardial perfusion imaging, which showed a large area of inferior ischemia. Subsequent coronary angiography revealed a chronic total occlusion (CTO) of the right coronary artery with brisk collateral flow from the left anterior descending artery (Figure 1). There was minimal obstructive disease in the remainder of the coronary tree. An attempt at percutaneous coronary intervention (PCI) was unsuccessful. He was treated with continuation of his medical therapy, although he remained with lifestyle-limiting class II to III angina. Figure 1. Left, The totally occluded right coronary artery with the expected course of the distal vessel outlined in red and the total occlusion shown by the arrow. Right, Collateralization of the right coronary artery from the left anterior descending (LAD) artery with arrows pointing to the posterior descending artery (PDA) and posterolateral ventricular (PLV) branches of the right coronary artery. The septal collaterals from the LAD to RCA are highlighted. Coronary CTO is characterized by heavy atherosclerotic plaque burden within the artery, resulting in complete (or nearly complete) occlusion of the vessel. Although the duration of the occlusion is difficult to determine on clinical grounds, a total occlusion must be present for at least 3 months to be considered a true CTO.1 Patients with CTO typically have collateralization of the distal vessel on coronary angiography, but these collaterals may not provide sufficient blood flow to the myocardial bed, resulting in ischemia and anginal symptoms. CTO is clinically distinct from acute coronary occlusion, which occurs in the setting of ST-segment–elevation myocardial infarction, or subacute coronary occlusion, discovered with delayed presentation after ST-segment–elevation myocardial infarction. Clinical features and treatment considerations of these entities differ considerably from CTO. Among patients who have a clinical …
- 26 April 2011
- Published by Wolters Kluwer Health in Circulation
- Vol. 123 (16) , 1780-1784
Management of Coronary Chronic Total Occlusion
A 67-year-old man with chronic stable angina presented with worsening angina to class III despite maximal medical therapy. He was referred for myocardial perfusion imaging, which showed a large area of inferior ischemia. Subsequent coronary angiography revealed a chronic total occlusion (CTO) of the right coronary artery with brisk collateral flow from the left anterior descending artery (Figure 1). There was minimal obstructive disease in the remainder of the coronary tree. An attempt at percutaneous coronary intervention (PCI) was unsuccessful. He was treated with continuation of his medical therapy, although he remained with lifestyle-limiting class II to III angina. Figure 1. Left, The totally occluded right coronary artery with the expected course of the distal vessel outlined in red and the total occlusion shown by the arrow. Right, Collateralization of the right coronary artery from the left anterior descending (LAD) artery with arrows pointing to the posterior descending artery (PDA) and posterolateral ventricular (PLV) branches of the right coronary artery. The septal collaterals from the LAD to RCA are highlighted. Coronary CTO is characterized by heavy atherosclerotic plaque burden within the artery, resulting in complete (or nearly complete) occlusion of the vessel. Although the duration of the occlusion is difficult to determine on clinical grounds, a total occlusion must be present for at least 3 months to be considered a true CTO.1 Patients with CTO typically have collateralization of the distal vessel on coronary angiography, but these collaterals may not provide sufficient blood flow to the myocardial bed, resulting in ischemia and anginal symptoms. CTO is clinically distinct from acute coronary occlusion, which occurs in the setting of ST-segment–elevation myocardial infarction, or subacute coronary occlusion, discovered with delayed presentation after ST-segment–elevation myocardial infarction. Clinical features and treatment considerations of these entities differ considerably from CTO. Among patients who have a clinical …